CLINICAL_TRIALS
trial_result
· 2016-02-01
Clinical Trial Update: Prasugrel and Ticagrelor in ST-segment Elevation Myocardial Infarction [Phase 3]
Summary
Phase 3 trial evaluating prasugrel and ticagrelor in ST-segment elevation myocardial infarction was terminated, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dong-A University | Conditions: ST-Segment Elevation Myocardial Infarction | Phase 3 | Status: TERMINATED | Results posted: 2016-02-01